Sotradecol (Sodium Tetradecyl Sulfate) Injection

OCTOBER 01, 2005

Bioniche Life Sciences Inc (Belleville, Ontario) has introduced Sotradecol Injection to the US market. The product is approved by the FDA for the treatment of small, uncomplicated varicose veins of the lower extremities. Sotradecol Injection is used in sclerotherapy (nonsurgical vein removal). An estimated 1.7 million individuals undergo sclerotherapy each year in the United States. Sotradecol Injection is available in 2 strengths, 1% and 3%, and is packaged in 2-mL vials. For more information, visit www.bioniche.com, or call 888-258-4199.



SHARE THIS SHARE THIS
0
 

5 Studies That Shaped HIV Treatment That Every Pharmacist Should Know
Over the years, a number of landmark clinical studies in the field of virology have been published, shaping how we treat many infectious diseases today.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.